• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.

作者信息

Casado Naranjo Ignacio, Portilla-Cuenca Juan Carlos, Jiménez Caballero Pedro Enrique, Calle Escobar Maria Luisa, Romero Sevilla Raúl Mauricio

机构信息

Department of Neurology, Stroke Unit, Hospital San Pedro de Alcántara, Cáceres, Spain.

出版信息

Cerebrovasc Dis. 2011;32(6):614-5. doi: 10.1159/000334578. Epub 2011 Dec 1.

DOI:10.1159/000334578
PMID:22133608
Abstract
摘要

相似文献

1
Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.在接受达比加群治疗的中风患者中，使用重组组织型纤溶酶原激活剂后发生致命性脑出血。
Cerebrovasc Dis. 2011;32(6):614-5. doi: 10.1159/000334578. Epub 2011 Dec 1.
2
Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.新型口服抗凝药物治疗的急性缺血性脑卒中患者的纤维蛋白溶解治疗
Cerebrovasc Dis. 2011;32(6):616-9. doi: 10.1159/000334579. Epub 2011 Dec 1.
3
Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.接受达比加群治疗的患者发生急性缺血性脑卒中，给予静脉组织型纤溶酶原激活物治疗，影像学显示再通。
J Stroke Cerebrovasc Dis. 2012 Nov;21(8):917.e5-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.003. Epub 2012 Jun 9.
4
Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.在接受达比加群治疗的患者中，静脉溶栓治疗急性卒中后预后良好。
Am J Emerg Med. 2014 Nov;32(11):1435.e1-2. doi: 10.1016/j.ajem.2014.04.021. Epub 2014 Apr 18.
5
Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.达比加群相关颅内出血导致血肿扩大。
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):e133-4. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.011. Epub 2013 Oct 6.
6
Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.达比加群治疗的患者中静脉注射组织型纤溶酶原激活剂治疗缺血性卒中
Acta Neurochir (Wien). 2012 Jan;154(1):87. doi: 10.1007/s00701-011-1196-x. Epub 2011 Oct 25.
7
Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.达比加群与华法林在心房颤动卒中预防中的比较。
Ann Intern Med. 2011 Apr 19;154(8):570; author reply 570-1. doi: 10.7326/0003-4819-154-8-201104190-00013.
8
Dabigatran for stroke prevention in all patients with atrial fibrillation?达比加群用于所有房颤患者的卒中预防？
Pharmacotherapy. 2011 Aug;31(8):725-8. doi: 10.1592/phco.31.8.725.
9
Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.达比加群酯与华法林在心房颤动患者中的比较：一项关于接受心脏转复术患者的分析。
Circulation. 2011 Jan 18;123(2):131-6. doi: 10.1161/CIRCULATIONAHA.110.977546. Epub 2011 Jan 3.
10
[Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].[药理说明书。达比加群，口服给药（Pradaxa）]
J Pharm Belg. 2012 Mar(1):37-8.

引用本文的文献

1
Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment.在急性缺血性脑卒中直接口服抗凝治疗中：溶栓治疗的安全性和预后改善的论证——从开始到结束。
Ann Neurol. 2024 Nov;96(5):871-886. doi: 10.1002/ana.27058. Epub 2024 Sep 11.
2
Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats.将美国食品药品监督管理局（FDA）批准的药物重新用作JNK3抑制剂，以预防大鼠大脑中动脉闭塞（MCAO）诱导的神经炎症。
J Inflamm Res. 2020 Dec 24;13:1185-1205. doi: 10.2147/JIR.S284471. eCollection 2020.
3
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.
急性护理和围手术期非维生素K拮抗剂口服抗凝剂治疗患者的管理：美国心脏协会科学声明
Circulation. 2017 Mar 7;135(10):e604-e633. doi: 10.1161/CIR.0000000000000477. Epub 2017 Feb 6.
4
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.家庭医疗中新型口服抗凝剂的应用：第2部分：解答常见问题
Can Fam Physician. 2014 Nov;60(11):997-1001.
5
Is intravenous recombinant tissue plasminogen activator (r-tPA) safe in patients on Dabigatran?在服用达比加群的患者中，静脉注射重组组织型纤溶酶原激活剂（r-tPA）是否安全？
J Vasc Interv Neurol. 2014 May;7(1):21-2.
6
Intravenous thrombolysis in a stroke patient receiving rivaroxaban.
Cerebrovasc Dis Extra. 2013 Oct 26;3(1):153-5. doi: 10.1159/000355839. eCollection 2013.
7
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.新型直接口服抗凝剂（DOACs），即阿哌沙班、达比加群和利伐沙班相关并发症的紧急处理建议。
Clin Res Cardiol. 2013 Jun;102(6):399-412. doi: 10.1007/s00392-013-0560-7. Epub 2013 May 14.
8
Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases.达比加群抗凝治疗的中风患者的溶栓治疗：病例报告及已发表病例综述
Case Rep Neurol. 2013 Mar 25;5(1):56-61. doi: 10.1159/000350570. Print 2013 Jan.
9
Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly.达比加群、加巴喷丁和伐昔洛韦的肾功能估计和剂量推荐：一项针对老年人的数据分析模拟研究。
BMJ Open. 2013 Apr 11;3(4). doi: 10.1136/bmjopen-2013-002686. Print 2013.
10
Thrombolysis in ischemic stroke patients on treatment with Dabigatran.达比加群治疗的缺血性中风患者的溶栓治疗
Intern Emerg Med. 2013 Aug;8(5):451-2. doi: 10.1007/s11739-013-0907-0. Epub 2013 Feb 7.